Portuguese consensus document for the management of alpha-1-antitrypsin deficiency
Alpha-1-antitrypsin deficiency (AATD) is a genetic autosomal codominant disorder caused by mutations in SERPINA1 gene. It is one of the most prevalent genetic disorders, although it remains underdiagnosed. Whereas at international level there are several areas of consensus on this disorder, in Portu...
| Published in: | Pulmonology |
|---|---|
| Main Authors: | A.P. Lopes, M.A. Mineiro, F. Costa, J. Gomes, C. Santos, C. Antunes, D. Maia, R. Melo, M. Canotilho, E. Magalhães, I. Vicente, C. Valente, B.G. Gonçalves, B. Conde, C. Guimarães, C. Sousa, J. Amado, M.E. Brandão, M. Sucena, M.J. Oliveira, S. Seixas, V. Teixeira, L. Telo |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2018-12-01
|
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1016/j.pulmoe.2018.09.004 |
Similar Items
The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil
by: Manuela Brisot Felisbino, et al.
by: Manuela Brisot Felisbino, et al.
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)
by: Chapman KR, et al.
Published: (2018-01-01)
Portuguese consensus document for the management of alpha-1-antitrypsin deficiency
by: A.P. Lopes, et al.
Published: (2018-12-01)
by: A.P. Lopes, et al.
Published: (2018-12-01)
Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01)
by: Bebiana Conde, et al.
Published: (2022-07-01)
The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
by: Robert A. Stockley, et al.
Published: (2023-08-01)
by: Robert A. Stockley, et al.
Published: (2023-08-01)
Alpha-1 Antitrypsin Gene Variants in Patients without Severe Deficiency Diagnosed with Pulmonary Emphysema on Chest CT
by: Laviña E, et al.
Published: (2024-02-01)
by: Laviña E, et al.
Published: (2024-02-01)
Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01)
by: Svetlana I. Melnik, et al.
Published: (2016-12-01)
Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
by: Dilek Karadoğan, et al.
Published: (2024-02-01)
by: Dilek Karadoğan, et al.
Published: (2024-02-01)
Cellular Consequences of Z Alpha-1 Antitrypsin Accumulation and Prospects for Therapy
by: Sam Alam, et al.
Published: (2013-12-01)
by: Sam Alam, et al.
Published: (2013-12-01)
Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy
by: Atharv V. Oak, MEng, et al.
Published: (2025-02-01)
by: Atharv V. Oak, MEng, et al.
Published: (2025-02-01)
Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency
by: Paulo Henrique Ramos Feitosa, et al.
Published: (2024-12-01)
by: Paulo Henrique Ramos Feitosa, et al.
Published: (2024-12-01)
Alpha1-antitrypsin deficiency in Greece: Focus on rare variants
by: S.A. Papiris, et al.
Published: (2024-01-01)
by: S.A. Papiris, et al.
Published: (2024-01-01)
Alpha-1 antitrypsin: now available, but do we need it?
by: Swiss Medical Weekly
Published: (2008-04-01)
by: Swiss Medical Weekly
Published: (2008-04-01)
No gender-specific differences in comorbidities in patients with chronic obstructive pulmonary disease due to alpha-1 antitrypsin deficiency
by: Josef Yayan, et al.
Published: (2023-11-01)
by: Josef Yayan, et al.
Published: (2023-11-01)
Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
by: Sebastian Fähndrich, et al.
Published: (2017-09-01)
by: Sebastian Fähndrich, et al.
Published: (2017-09-01)
Prevalence of alpha-1 antitrypsin deficiency in patients with acute exacerbation of chronic obstructive pulmonary disease: Insights from a prospective study
by: AK Rayees, et al.
Published: (2024-06-01)
by: AK Rayees, et al.
Published: (2024-06-01)
Case Report: α1-antitrypsin deficiency causing persistent pleural effusion and multilobar alveolar emphysema in a young dog
by: Pavlos G. Doulidis, et al.
Published: (2025-10-01)
by: Pavlos G. Doulidis, et al.
Published: (2025-10-01)
Development of a small molecule that corrects misfolding and increases secretion of Z α1‐antitrypsin
by: David A Lomas, et al.
Published: (2021-01-01)
by: David A Lomas, et al.
Published: (2021-01-01)
Assessing the efficacy of Alpha1-Proteinase inhibitor (human) augmentation therapy for Alpha1-Antitrypsin deficiency – Related emphysema: Challenges and opportunities
by: L. Ross Pierce
Published: (2024-06-01)
by: L. Ross Pierce
Published: (2024-06-01)
In Vivo Electroporation-Mediated, Intrahepatic Alpha1 Antitrypsin Gene Transfer Reduces Pulmonary Emphysema in Pallid Mice
by: Marco A. Sutter, et al.
Published: (2020-08-01)
by: Marco A. Sutter, et al.
Published: (2020-08-01)
Prevalence of genetic mutations in alpha-1 antitrypsin deficiency (aatd) in patients with chronic obstructive pulmonary disease in Colombia
by: Abraham Alí-Munive, et al.
Published: (2023-05-01)
by: Abraham Alí-Munive, et al.
Published: (2023-05-01)
Emphysema and COPD in a young woman
by: Kevin Conroy, et al.
Published: (2014-01-01)
by: Kevin Conroy, et al.
Published: (2014-01-01)
Diagnosis of alpha1-antitrypsin deficiency not just in severe COPD
by: A. Nuñez, et al.
Published: (2018-11-01)
by: A. Nuñez, et al.
Published: (2018-11-01)
Characterization of three new SERPINA1 variants PiQ0Heidelberg II, PiQ0Heidelberg III and PiQ0Heidelberg IV in patients with severe alpha-1 antitrypsin deficiency
by: Philipp Höger, et al.
Published: (2023-01-01)
by: Philipp Höger, et al.
Published: (2023-01-01)
PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)
Assessment and monitoring of lung disease in patients with severe alpha 1 antitrypsin deficiency: a european delphi consensus of the EARCO group
by: Marc Miravitlles, et al.
Published: (2024-08-01)
by: Marc Miravitlles, et al.
Published: (2024-08-01)
Liver-directed SERPINA1 gene therapy attenuates progression of spontaneous and tobacco smoke-induced emphysema in α1-antitrypsin null mice
by: Marina Zieger, et al.
Published: (2022-06-01)
by: Marina Zieger, et al.
Published: (2022-06-01)
Applications of Artificial Intelligence in Alpha-1 Antitrypsin Deficiency: A Systematic Review from a Respiratory Medicine Perspective
by: Manuel Casal-Guisande, et al.
Published: (2025-09-01)
by: Manuel Casal-Guisande, et al.
Published: (2025-09-01)
THE DIAGNOSTIC AND CLINICAL VALUE OF DETERMINATION OF α1-ANTITRYPSIN PHENOTYPE IN SYSTEMIC VASCULITIDES
by: M. Yu. Pervakova, et al.
Published: (2017-04-01)
by: M. Yu. Pervakova, et al.
Published: (2017-04-01)
Characterization of alpha-1 antitrypsin in a Pi∗ZZ patient with emphysema: a case report
by: Arturo Olivares Rivera, et al.
Published: (2025-01-01)
by: Arturo Olivares Rivera, et al.
Published: (2025-01-01)
The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Dawid Kościołek, et al.
Published: (2024-02-01)
by: Dawid Kościołek, et al.
Published: (2024-02-01)
Défice de alfa -1 antitripsina. A experiência do Hospital de Pulido Valente com a terapêutica de reposição Alpha -1 antitrypsin deficiency. The experience of Pulido Valente Hospital with augmentation therapy
by: Carla Alves Costa, et al.
Published: (2009-05-01)
by: Carla Alves Costa, et al.
Published: (2009-05-01)
Polymorphism of alpha-1-antitrypsin in hematological malignancies
by: Aleksandra Topic, et al.
Published: (2009-01-01)
by: Aleksandra Topic, et al.
Published: (2009-01-01)
Alpha-1 antitrypsin deficiency-associated panniculitis: a case report
by: Špela But, et al.
Published: (2025-06-01)
by: Špela But, et al.
Published: (2025-06-01)
Occurrence of Emphysema in Individuals With Williams-Beuren SyndromeTake-home Points
by: Uddalak Majumdar, MD, et al.
Published: (2025-03-01)
by: Uddalak Majumdar, MD, et al.
Published: (2025-03-01)
Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)
by: Mark Brantly, et al.
Published: (2020-04-01)
“Alpha-1, are you in? (C)harlie (O)scar (P)appa (D)elta, over!”
by: G. L. Muntingh
Published: (2016-01-01)
by: G. L. Muntingh
Published: (2016-01-01)
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01)
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01)
Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin
by: Torres-Durán M, et al.
Published: (2023-08-01)
by: Torres-Durán M, et al.
Published: (2023-08-01)
The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
by: Tobias Meischl, et al.
Published: (2023-01-01)
by: Tobias Meischl, et al.
Published: (2023-01-01)
Similar Items
-
The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil
by: Manuela Brisot Felisbino, et al. -
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01) -
Portuguese consensus document for the management of alpha-1-antitrypsin deficiency
by: A.P. Lopes, et al.
Published: (2018-12-01) -
Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01) -
The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
by: Robert A. Stockley, et al.
Published: (2023-08-01)
